relafen ds

Generic: nabumetone

Labeler: carwin pharmaceutical associates, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name relafen ds
Generic Name nabumetone
Labeler carwin pharmaceutical associates, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nabumetone 1000 mg/1

Manufacturer
Carwin Pharmaceutical Associates, LLC

Identifiers & Regulatory

Product NDC 15370-170
Product ID 15370-170_48aa3640-1dd2-4693-9b0d-a99595b97a0e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203166
Listing Expiration 2026-12-31
Marketing Start 2019-09-20

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 15370170
Hyphenated Format 15370-170

Supplemental Identifiers

RxCUI
427726 2200291
UPC
0315370170308
UNII
LW0TIW155Z
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name relafen ds (source: ndc)
Generic Name nabumetone (source: ndc)
Application Number ANDA203166 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1000 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE, PLASTIC (15370-170-10)
  • 30 TABLET in 1 BOTTLE, PLASTIC (15370-170-30)
  • 60 TABLET in 1 BOTTLE, PLASTIC (15370-170-60)
  • 1 BLISTER PACK in 1 CARTON (15370-170-99) / 2 TABLET in 1 BLISTER PACK
source: ndc

Packages (4)

15370-170-10 100 TABLET in 1 BOTTLE, PLASTIC (15370-170-10) 15370-170-30 30 TABLET in 1 BOTTLE, PLASTIC (15370-170-30) 15370-170-60 60 TABLET in 1 BOTTLE, PLASTIC (15370-170-60) 15370-170-99 1 BLISTER PACK in 1 CARTON (15370-170-99) / 2 TABLET in 1 BLISTER PACK

Ingredients (1)

nabumetone (1000 mg/1)

Linked Drug Pages (1)

RELAFEN DS ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48aa3640-1dd2-4693-9b0d-a99595b97a0e", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0315370170308"], "unii": ["LW0TIW155Z"], "rxcui": ["427726", "2200291"], "spl_set_id": ["a9a0af85-6c43-4a2d-ba75-0be4ca64c931"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Carwin Pharmaceutical Associates, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (15370-170-10)", "package_ndc": "15370-170-10", "marketing_start_date": "20220512"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (15370-170-30)", "package_ndc": "15370-170-30", "marketing_start_date": "20190920"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (15370-170-60)", "package_ndc": "15370-170-60", "marketing_start_date": "20200228"}, {"sample": true, "description": "1 BLISTER PACK in 1 CARTON (15370-170-99)  / 2 TABLET in 1 BLISTER PACK", "package_ndc": "15370-170-99", "marketing_start_date": "20200228"}], "brand_name": "RELAFEN DS", "product_id": "15370-170_48aa3640-1dd2-4693-9b0d-a99595b97a0e", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "15370-170", "generic_name": "NABUMETONE", "labeler_name": "Carwin Pharmaceutical Associates, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RELAFEN DS", "active_ingredients": [{"name": "NABUMETONE", "strength": "1000 mg/1"}], "application_number": "ANDA203166", "marketing_category": "ANDA", "marketing_start_date": "20190920", "listing_expiration_date": "20261231"}